Embedded Files
India's Full Stack Microbiome Health Solution
PulseTech is India's leading full-stack microbiome platform. Probiotics have a profound power to influence our quality of life - from stomach acidity, to acne, to anxiety. Sova Health offers a three step process for solving microbiome health issues - start with biome-genome test - then work with a coach to change your behavior, and finally add supplements to cultivate the ideal microbiome.
Our Investors
Our Investors
Watch the Founder Interview
Watch the Founder Interview
Watch the Clueless Capitalist interview with PulseTech's founder Kazi Rasul
Key Highlights:
Problem Solved:
Bangladesh's $10B pharmaceutical market faces significant challenges
98% of pharmacies lack reliable software, leading to $330M in annual losses from counterfeit products,
$74M worth of expired products, and
5-9% higher costs in order collection and distribution.
Pulse Tech is directly tackling these issues with its innovative approach.
Co-founder Advantage:
With co-founder Arefin being deeply entrenched in the pharmaceutical industry through Techno Drugs—a leading company that went public in 2024—Pulse Tech benefits from unparalleled market insights and expertise.
This gives Pulse Tech a competitive edge and positions it for potential future IPO success.
Customer Acquisition Success:
Pulse Tech has reduced its CAC from $35 to $1, proving the scalability and effectiveness of its digital model.
Market Opportunity:
With strong government support for digital health solutions and a projected $10B pharma market by 2030, Pulse Tech is well-positioned to capture significant growth in this rapidly evolving sector.
💸 Investor Alert: Pulse Tech is in its pre-seed stage, presenting a compelling opportunity for early investors seeking to engage in Bangladesh’s expanding pharma sector.
Google Sites
Report abuse